• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

患癌儿童的季节性流感

Seasonal Influenza in Children With Cancer.

作者信息

Daniels Preston, Danziger-Isakov Lara, Otto William

机构信息

Internal Medicine, Rush University Medical Center, Chicago, USA.

Pediatric Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.

出版信息

Cureus. 2024 Oct 31;16(10):e72785. doi: 10.7759/cureus.72785. eCollection 2024 Oct.

DOI:10.7759/cureus.72785
PMID:39618559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11608092/
Abstract

Influenza is a major cause of morbidity and mortality for pediatric cancer patients. We review important aspects in the management of influenza, including virology, epidemiology, clinical presentation, diagnostic testing, and antiviral treatment. Topics that are addressed include optimal treatment of influenza in children with cancer as well as strategies for prevention. This includes both pre-/post-exposure chemoprophylaxis and vaccination.

摘要

流感是儿科癌症患者发病和死亡的主要原因。我们回顾了流感管理中的重要方面，包括病毒学、流行病学、临床表现、诊断检测和抗病毒治疗。涉及的主题包括癌症儿童流感的最佳治疗以及预防策略。这包括暴露前/暴露后化学预防和疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60c/11608092/0444ecc6988c/cureus-0016-00000072785-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60c/11608092/171998f511fe/cureus-0016-00000072785-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60c/11608092/0444ecc6988c/cureus-0016-00000072785-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60c/11608092/171998f511fe/cureus-0016-00000072785-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60c/11608092/0444ecc6988c/cureus-0016-00000072785-i02.jpg

相似文献

1
Seasonal Influenza in Children With Cancer.患癌儿童的季节性流感
Cureus. 2024 Oct 31;16(10):e72785. doi: 10.7759/cureus.72785. eCollection 2024 Oct.
2
Recommendations for Prevention and Control of Influenza in Children, 2023-2024.《2023 - 2024年儿童流感预防与控制建议》
Pediatrics. 2023 Oct 1;152(4). doi: 10.1542/peds.2023-063773.
3
Recommendations for Prevention and Control of Influenza in Children, 2024-2025: Technical Report.2024-2025 年度预防和控制儿童流感的建议：技术报告。
Pediatrics. 2024 Oct 1;154(4). doi: 10.1542/peds.2024-068508.
4
Recommendations for Prevention and Control of Influenza in Children, 2022-2023.2022-2023 年度儿童流感预防和控制建议
Pediatrics. 2022 Oct 1;150(4). doi: 10.1542/peds.2022-059275.
5
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南（2020—2021年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
6
[Technical guidelines for seasonal influenza vaccination in China, 2019-2020].《中国2019-2020年季节性流感疫苗接种技术指南》
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1333-1349. doi: 10.3760/cma.j.issn.0254-6450.2019.11.002.
7
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南（2020—2021年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1555-1576. doi: 10.3760/cma.j.cn112338-20200904-01126.
8
Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.2009 年甲型 H1N1 流感病毒疫苗与季节性流感疫苗同时接种于接受化疗的儿童中的免疫原性。
Pediatr Blood Cancer. 2014 Jun;61(6):1013-6. doi: 10.1002/pbc.24893. Epub 2014 Jan 3.
9
Recommendations for Prevention and Control of Influenza in Children, 2018-2019.2018-2019 年度儿童流感预防与控制建议
Pediatrics. 2018 Oct;142(4). doi: 10.1542/peds.2018-2367. Epub 2018 Sep 3.
10
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南（2021—2022年）》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.

本文引用的文献

1
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.疫苗预防和控制季节性流感：免疫实践咨询委员会的建议-美国，2024-25 流感季节。
MMWR Recomm Rep. 2024 Aug 29;73(5):1-25. doi: 10.15585/mmwr.rr7305a1.
2
Masks and respirators for prevention of respiratory infections: a state of the science review.口罩和呼吸防护器预防呼吸道感染：科学综述。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0012423. doi: 10.1128/cmr.00124-23. Epub 2024 May 22.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.
物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer.从接受癌症治疗的免疫功能低下儿童流感疫苗接种中吸取的经验教训。
Lancet Child Adolesc Health. 2023 Mar;7(3):199-213. doi: 10.1016/S2352-4642(22)00315-7. Epub 2023 Jan 24.
5
Diagnostic accuracy of multiplex respiratory pathogen panels for influenza or respiratory syncytial virus infections: systematic review and meta-analysis.多重呼吸道病原体检测 panel 对流感或呼吸道合胞病毒感染的诊断准确性：系统评价和荟萃分析。
BMC Infect Dis. 2022 Oct 13;22(1):785. doi: 10.1186/s12879-022-07766-9.
6
Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020.2007-2020 年，奥司他韦早期治疗与住院流感儿童临床结局改善的相关性。
JAMA Pediatr. 2022 Nov 1;176(11):e223261. doi: 10.1001/jamapediatrics.2022.3261. Epub 2022 Nov 7.
7
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).美国传染病学会关于 COVID-19 患者治疗和管理的指南（2022 年 9 月）。
Clin Infect Dis. 2024 Jun 27;78(7):e250-e349. doi: 10.1093/cid/ciac724.
8
Influenza.流感。
Lancet. 2022 Aug 27;400(10353):693-706. doi: 10.1016/S0140-6736(22)00982-5.
9
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.重度流感住院患者中玛巴洛沙韦与标准治疗神经氨酸酶抑制剂联合用药（FLAGSTONE）：一项随机、平行组、双盲、安慰剂对照的优效性试验。
Lancet Infect Dis. 2022 May;22(5):718-730. doi: 10.1016/S1473-3099(21)00469-2. Epub 2022 Jan 24.
10
Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol.儿童患者（6 至＜12 岁）流感患者中比奥司他韦相比巴洛沙韦的临床和病毒学结局：一项开放标签、随机、活性对照试验方案。
BMC Infect Dis. 2021 Aug 9;21(1):777. doi: 10.1186/s12879-021-06494-w.